TERT promoter mutations in familial and sporadic melanoma
- PMID: 23348503
- DOI: 10.1126/science.1230062
TERT promoter mutations in familial and sporadic melanoma
Abstract
Cutaneous melanoma occurs in both familial and sporadic forms. We investigated a melanoma-prone family through linkage analysis and high-throughput sequencing and identified a disease-segregating germline mutation in the promoter of the telomerase reverse transcriptase (TERT) gene, which encodes the catalytic subunit of telomerase. The mutation creates a new binding motif for Ets transcription factors and ternary complex factors (TCFs) near the transcription start and, in reporter gene assays, caused up to twofold increase in transcription. We then screened the TERT promoter in sporadic melanoma and observed recurrent ultraviolet signature somatic mutations in 125 of 168 (74%) of human cell lines derived from metastatic melanomas, 45 of 53 corresponding metastatic tumor tissues (85%), and 25 of 77 (33%) primary melanomas. The majority of those mutations occurred at two positions in the TERT promoter and also generated binding motifs for Ets/TCF transcription factors.
Similar articles
-
Highly recurrent TERT promoter mutations in human melanoma.Science. 2013 Feb 22;339(6122):957-9. doi: 10.1126/science.1229259. Epub 2013 Jan 24. Science. 2013. PMID: 23348506 Free PMC article.
-
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.Nat Commun. 2014 Feb 26;5:3401. doi: 10.1038/ncomms4401. Nat Commun. 2014. PMID: 24569790
-
TERT promoter mutation is uncommon in acral lentiginous melanoma.J Cutan Pathol. 2014 Jun;41(6):504-8. doi: 10.1111/cup.12323. Epub 2014 Apr 2. J Cutan Pathol. 2014. PMID: 24588324
-
TERT promoter mutations in cancer development.Curr Opin Genet Dev. 2014 Feb;24:30-7. doi: 10.1016/j.gde.2013.11.005. Epub 2013 Dec 20. Curr Opin Genet Dev. 2014. PMID: 24657534 Review.
-
Ets2 transcription factor, telomerase activity and breast cancer.Clin Exp Pharmacol Physiol. 2010 Jan;37(1):83-7. doi: 10.1111/j.1440-1681.2009.05236.x. Epub 2009 Jun 29. Clin Exp Pharmacol Physiol. 2010. PMID: 19566835 Review.
Cited by
-
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.Acta Neuropathol Commun. 2020 Aug 25;8(1):145. doi: 10.1186/s40478-020-01022-4. Acta Neuropathol Commun. 2020. PMID: 32843091 Free PMC article.
-
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.Eur J Cancer. 2015 May;51(8):969-76. doi: 10.1016/j.ejca.2015.03.010. Epub 2015 Apr 2. Eur J Cancer. 2015. PMID: 25843513 Free PMC article.
-
Telomerase Regulation: A Role for Epigenetics.Cancers (Basel). 2021 Mar 10;13(6):1213. doi: 10.3390/cancers13061213. Cancers (Basel). 2021. PMID: 33802026 Free PMC article. Review.
-
The role of enhancers in cancer.Nat Rev Cancer. 2016 Aug;16(8):483-93. doi: 10.1038/nrc.2016.62. Epub 2016 Jul 1. Nat Rev Cancer. 2016. PMID: 27364481 Review.
-
The prognostic power of gene mutations in thyroid cancer.Endocr Connect. 2024 Jan 16;13(2):e230297. doi: 10.1530/EC-23-0297. Print 2024 Feb 1. Endocr Connect. 2024. PMID: 38078934 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials